Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

A thorough history and examination are crucial for diagnosing skin diseases, which affect up to a third of people. This includes details about skin lesions, medication, general health, lifestyle, family, and contacts, as well as examining the rash, hair, nails, and mucous membranes. Changes in hair and nails can also indicate other medical and skin disorders.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

A woman with hair loss had a benign sweat duct tumor found during a scalp biopsy.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Sensitive skin is often caused by nerve fibers and environmental factors, and can be managed with mild skincare and professional advice.

Treatments for melanin disorders exist, but more effective options needed.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The most common skin problems in Indian children are infections and eczemas.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Trichoscopy helps tell apart scalp lesions in pemphigus vulgaris and pemphigus foliaceus and is useful for choosing biopsy locations.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Dermoscopy now helps diagnose various skin, hair, and nail issues, improving patient care and treatment understanding.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Some skin diseases and their treatments can negatively affect male fertility.

Environmental and cosmetic factors, including heat, chemicals, and sun exposure, can cause hair loss and damage.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Scalp fungus infections in Spain are a health concern, with changing causes and a need for better treatment and prevention.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.